Table 9.11a

Adjusted Patient Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 8,879 93.0% 0.3% 8,879 86.9% 0.4% 16,846 79.1% 0.4% 24,621 72.9% 0.4%
Primary Diagnosis Non-Cholestatic Cirrhosis 5,615 93.4% 0.3% 5,615 86.8% 0.5% 10,984 78.5% 0.5% 16,183 71.6% 0.5%
Cholestatic Liver Disease/Cirrhosis 852 94.7% 0.8% 852 91.0% 1.0% 1,664 85.4% 1.0% 2,580 80.6% 0.9%
Acute Hepatic Necrosis 629 87.0% 1.4% 629 80.3% 1.6% 1,329 73.6% 1.4% 1,964 70.0% 1.3%
Biliary Atresia 295 92.2% 2.0% 295 90.1% 2.3% 582 87.7% 1.9% 911 83.3% 1.7%
Metabolic Diseases 297 94.6% 1.4% 297 90.7% 1.8% 588 84.7% 1.8% 858 81.4% 1.6%
Malignant Neoplasms 603 94.2% 0.9% 603 86.7% 1.4% 789 70.4% 2.5% 959 59.6% 2.7%
Other 588 91.6% 1.2% 588 85.7% 1.5% 910 78.9% 1.6% 1,166 70.6% 1.9%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.